NASA Country Reports

This report includes the results of the second National AIDS Spending Assessment (NASA II) in Cambodia, covering the fiscal years 2007 and 2008. NASA II was carried out from December 2008 to January 2009 under the leadership of the National AIDS Authority (NAA). It was designed to build in a coherent manner on NASA I which was carried out at the end of 2007 and covered the year 2006.

NASA 2007 aimed to assess overall spending on the HIV/AIDS programme by examining programme financial flows – Sources of Funds, Agents, and Providers - beneficiary population, and specific functions and programmes where spending was being made. Attempt was made to see if sufficient resources were being invested in enhancing the capacity of the organizations’
human resources to implement HIV/AIDS programme activities, as well as to enhancing overall national capacity for external and internal resource mobilisation.

The National AIDS Spending Assessment (NASA) is a tool/ method that had been introduced by the UNAIDS Geneva to measure the commitment of a nation in combating a global epidemic disease such as HIV and AIDS. The development of NASA 2006-2007 is a jointly teamwork involved highly motivated senior staffs of the National AIDS Commission, UNAIDS Indonesia, Department of Health and other Sectors at the central level, as well as colleagues from 3 selected provinces.

The HIV/AIDS situation in the country can be described as hidden and growing. Based on the HIV/AIDS Registry of the National Epidemiology Center (NEC) of the Department of Health (DOH), the cumulative number of HIV/Ab seropositive cases has reached 2,373 since 1984. Epidemiologists and experts, however, estimate that the actual number of HIV cases is around 10,000. Despite the increasing number of cases, the prevalence rate remains consistently below one percent.

HIV/AIDS spending in Thailand was 4,943.32 millions baht (122.90 million USD) in 2004, nearly doubled from that of 2,623.27 millions baht (65.4 million USD) in 2000. HIV/AIDS spending per capita increased from 1.05 USD in 2000 to 1.91 USD in 2004 while expenditure per capita PLWA increased dramatically 2.3 times from 94.19 USD in 2000 to 214.68 USD in 2004. In addition, the share of HIV/AIDS expenditure to total health expenditure (THE) increased from 1.57% in 2000 to 2.64% in 2004.